Anekant Pharmaceuticals Private Limited, a active private limited company, was established on 06 February 2017 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U36100DL2017PTC311457. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.55 M.
Formerly known as Seramejor Technologies Private Limited, Invent Pharma Agencies Private Limited. It upholds a compliant status. Its leadership includes Jai Krishan Aggarwal (Director), Pankaj Jain (Additional Director), Motilal Chawla (Director). Past directors included Anju Rastogi, Amit Rastogi, Jai Krishan Aggarwal. It holds ₹1.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at B-399 Nirman Vihar, Delhi, Delhi, 110092.
U36100DL2017PTC311457
311457
06 February 2017
₹5.00 M
₹0.55 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Anekant Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jai Krishan Aggarwal | Director | 31 Jul 2020 | Current |
| Pankaj Jain | Additional Director | 10 Oct 2021 | Current |
| Motilal Chawla | Director | 01 May 2023 | Current |
| Ashish Kumar Singh | Director | 31 Jul 2020 | Current |
| Anil Kumar | Director | 01 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 15 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 02 May 2023 | Past |
| Pramod Abcsdd | Director | 25 Aug 2021 | Past |
| Pramod Abcsdd | Director | 10 Oct 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Director | 11 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anekant Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 54.32% increase. The company also saw a slight improvement in profitability, with a 7.89% increase in profit. The company's net worth Soared by an impressive increase of 97.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Anekant Pharmaceuticals had a promoter holding of 76.67% and a public holding of 23.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2021 | Others | ₹1.10 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Anekant Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Anekant Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anekant Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Motilal Chawla was appointed as a Director was appointed as a Director on 01 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Progress on Anil Kumar was appointed as a Director was appointed as a Director on 01 May 2023 & has been associated with this company since 2 years 7 months . was documented.
Progress on Anekant Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Pankaj Jain was appointed as a Additional Director was appointed as a Additional Director on 10 Oct 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
The activity Anekant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was completed.
A charge with Others amounted to Rs. 11.00 M with Charge ID 100413520 was registered on 03 Feb 2021. was recorded as a recent event.
The CIN of Anekant Pharmaceuticals Private Limited is U36100DL2017PTC311457.
Anekant Pharmaceuticals Private Limited is headquartered at B-399 Nirman Vihar, Delhi, Delhi, 110092.
Anekant Pharmaceuticals Private Limited was incorporated on 06 February 2017.
The current directors of Anekant Pharmaceuticals Private Limited are
The primary industry of Anekant Pharmaceuticals Private Limited is Trade.
Anekant Pharmaceuticals Private Limited is unlisted.
The authorized capital of Anekant Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.55 M.
The compliance status of Anekant Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX